Health-Tourism-Review-Articles
Health
tourism is actually thousands of years old. In ancient Greece, pilgrims and patients came from everywhere the Mediterranean to the sanctuary of the healing god, Asklepios, at Epidaurus. In Roman Britain, patients took the waters at a shrine at Bath, a practice that continued for 2000 years. From the 18th century wealthy Europeans travelled to spas from Germany to the Nile. Since the first nineteenth century, when there have been no restrictions on travel in Europe, people visited neighboring countries so as to enhance their health. In the 21st century, relatively low-cost jet travel has taken the industry beyond the rich and desperate. Later, mostly wealthy people began traveling to tourist destinations a bit like Swiss lakes, Alps and special
tuberculosis sanatoriums, where professional and sometimes specialized medical care was offered. In this century, however, medical
tourism expanded to a way larger scale.
Tourism arranged the travel industry goals, for example, comprehensive retreats, gated resort networks, private luxury ship possessed islands and privatized sea shores, have expanded in the course of the most recent couple of decades. Scientists have broke down these sorts of the travel industry situations as enclaves, which are normally determined by outer powers and entertainers, emphatically upheld by globalization and the current neoliberal market economy. Existing exploration shows that travel industry enclaves are portrayed by dynamic fringe making, power issues and material as well as emblematic partition from the encompassing socio-social real factors, prompting feeble linkages with has networks and the nearby economy.
High Impact List of Articles
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
Relevant Topics in Clinical